CNMD
CONMED Corporation · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website conmed.com
- Employees(FY) 4100
- ISIN US2074101013
Performance
-5.27%
1W
-4.07%
1M
-8.65%
3M
+2.27%
6M
-36.64%
YTD
-36.0%
1Y
Profile
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Technical Analysis of CNMD 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-17 19:00
CNMD: Lowering target price to $75.00(Argus Research)
- 2024-12-13 09:40
- 2024-12-13 05:45
CONMED's (NYSE:CNMD) Dividend Will Be $0.20(Simply Wall St.)
- 2024-12-11 09:45
- 2024-12-10 19:00
CNMD: Lowering target price to $78.00(Argus Research)
- 2024-12-10 07:00
CONMED Corporation Announces Quarterly Cash Dividend(Business Wire)
- 2024-12-09 18:00
CONMED Corporation Announces Quarterly Cash Dividend(Businesswire)
- 2024-12-07 08:11
- 2024-12-03 19:00
CNMD: Raising target price to $79.00(Argus Research)
- 2024-11-29 08:54
- 2024-11-27 09:40
- 2024-11-26 19:00
CNMD: Raising target price to $78.00(Argus Research)
- 2024-11-25 09:45
- 2024-11-18 16:05
- 2024-11-18 03:05
- 2024-11-15 09:50
- 2024-11-12 19:00
CNMD: Raising target price to $79.00(Argus Research)
- 2024-11-11 09:40
- 2024-11-08 09:45
- 2024-11-05 19:00
CNMD: Raising target price to $78.00(Argus Research)
- 2024-11-04 16:05
- 2024-11-04 03:05
- 2024-11-02 08:25
- 2024-11-01 06:57
Is CONMED Corporation (NYSE:CNMD) Trading At A 49% Discount?(Simply Wall St.)
- 2024-11-01 06:45
CONMED Third Quarter 2024 Earnings: EPS Beats Expectations(Simply Wall St.)
- 2024-10-31 08:42
- 2024-10-30 21:01
- 2024-10-30 19:00
- 2024-10-30 18:20
- 2024-10-30 17:22
Conmed: Q3 Earnings Snapshot(Associated Press Finance)
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.